Jason Hoskins is a strategic initiatives manager in the Office of Entrepreneurship & Commercialization. He joined OEC in January 2026 and his role supports the development, licensing, and commercialization of MSK technology.
Previously, Jason was a healthcare and life sciences consultant at The Dedham Group where he developed strategic recommendations for expanding patient access to cell and gene therapies on a global scale.
Jason received his bachelor’s degree from the University of Pennsylvania in 2021, majoring in Health & Societies with a concentration on healthcare markets and management.